HTA167 Another Hurdle in Anticancer New Drug Listing in Korea—Setting the Reimbursement Scope
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.1851
https://www.valueinhealthjournal.com/article/S1098-3015(23)04981-1/fulltext
Title :
HTA167 Another Hurdle in Anticancer New Drug Listing in Korea—Setting the Reimbursement Scope
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)04981-1&doi=10.1016/j.jval.2023.09.1851
First page :
Section Title :
Open access? :
No
Section Order :
11294